Google
 

30 Mei 2014

Re: [Dokter Umum] mohon konfirmasi

 

Saya mendapat info ini dari teman saya mohon konfirmasi/penjelasan dr dokter apakah hal ini benar ? Terima kasih dok

INFO PENTING... Memakai hp di tempat yang gelap, mudah kehilangan penglihatan. Terutama orang yang biasa surf internet sebelum tidur, akan menjadi masalah yang besar. Semakin hari semakin banyak pasien yang berumur yang datang berobat, yang disebabkan oleh kebiasaan memakai"smart phone" di kamar tidur setelah mematikan lampu.Cahaya hp yang terang yg masuk ke mata melebihi 30menit, akan menyebabkan kerusakan pada bagian macula lutea (bagian dr retina), yang beresiko pd penurunan penglihatan yang drastis, terutama penyakit pada macula lutea yang tidak dapat disembuhkan. Bila macula lutea rusak, maka hanya tinggal waktu akan terkena kanker mata, menunggu saat menjadi buta, karena ilmu kedokteran skrg masih belum sanggup utk mengobati penyakit tsb.Setelah lampu ruangan dipadamkan, cahaya pada layar hp sangatlah terang, melihat hp dalam jarak dekat, cahaya dgn intensitas tinggi masuk kedalam mata, langsung merusak macula lutea. Gejala penyakit macula lutea umumnya terdapat pada org tua, tetapi belakangan ini terdapat pasien yang berusia muda (anak2/remaja). Diantaranya kebanyakan pasien tsb merupakan pemakai smart phone dgn intensitas tinggi. Bukan hanya kerusakan pada macula lutea, pada awalnya bisa menyebabkan mata kering, katarak, kerusakan penglihatan, kemudian menjadi buta. Pada tahap awal, pasien harus dilaser atau disuntik steroid, baru bisa sembuh. Disarankan, selain minum supplemen lutein, lebih penting adalah menghilangkan kebiasaan buruk memakai hp. Dikarenakan sebelum tidur, tidak dapat menahan diri utk tdk memakai hp, maka menyebabkan akibat yg mengerikan seumur hidup... JANGAN DIABAIKAN PESAN PENTING INI BUAT KITA DAN TERUTAMA BUAT PENGLIHATAN ANAK2 KITA..!! bc info ini...33

Sent from Yahoo Mail on Android



From: Dr.(Naturopathy) Ir. Donny Hosea MBA. PhD. Acs <puyuh23@indo.net.id>;
To: <dokter_umum@yahoogroups.com>;
Subject: Re: [Dokter Umum] Tanya Hasil Lab Darah
Sent: Fri, May 2, 2014 2:55:54 AM

 

Hello,

Milis tdk dapat menerima attachment, oleh karena itu salinlah hasilnya,
Terima kasih,
Salam,

On 5/1/2014 4:07 PM, Jack Sparrow wrote:
Selamat sore pak Dokter..  Boleh saya dapat gambaran cara baca hasil lab darah anak saya terlampir?.    Trims sebelumnya     Salam  Gus Bah    Sent from my iPhone         ----------          Sent from my iPhone 5    [Non-text portions of this message have been removed]        ------------------------------------    [ Forum Kesehatan : http://www.medisiana.com ]Yahoo Groups Links    <*> To visit your group on the web, go to:      http://groups.yahoo.com/group/dokter_umum/    <*> Your email settings:      Individual Email | Traditional    <*> To change settings online go to:      http://groups.yahoo.com/group/dokter_umum/join      (Yahoo! ID required)    <*> To change settings via email:      dokter_umum-digest@yahoogroups.com       dokter_umum-fullfeatured@yahoogroups.com    <*> To unsubscribe from this group, send an email to:      dokter_umum-unsubscribe@yahoogroups.com    <*> Your use of Yahoo Groups is subject to:      https://info.yahoo.com/legal/us/yahoo/utos/terms/      

--

__._,_.___

Posted by: "grace_suraji@yahoo.com" <grace_suraji@yahoo.com>
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (4)
[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

16 Mei 2014

Re: [Dokter Umum] GLukoma

 

Hello Rekaman11, Mono,

Galucoma adalah bentuk kerusakan jaringan sebagai akibat dari sesuatu hal yg membuat tekanan pada bidang lihat mata sehingga rusak.

Mungkinkah suatu kerusakan jaringan yg fatal lalu bisa disembuhkan oleh alternative?
Apa yg dilakukan sang alternative? menggantinya? bisakah tanpa operasi? bisakah diganti jaringan itu tanpa melakukan tindakan operasi?

maka jalan satu2nya adalah bila masih mungkin dlm pemerikasaan, dimana jaringan sebut saja kameranya masih baik adalah melakukan upaya agar tekanan merendah n perbaikan jaringan terjadi.
Bila sdh rusak, maka operasi penggantian kamera (cornea / bidang penerimaan cahaya n object) dg biaya ygt sangat besar mungkin bisa berhasil.
Disamping team dokter, juga dibutuhkan donatur mata yg sehat n compatible

Demikian, semoga bermanfaat,
Salam,


On 5/15/2014 8:32 PM, rekaman11@yahoo.com [dokter_umum] wrote:

Dear Dokter,


Saya sudah divonis terkena Penyakit Glukoma, bagaimana caranya menghilangkan penyakit ini?

Bisakah menggunakan dengan cara alternatif?


Mohon jawabannya, terima kasih


Regards

Mono



--
We Care

-- We care human as human not as sickness object

 "Absolutely Drug less Health Care solution Organization"

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (2)

[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

15 Mei 2014

[Dokter Umum] GLukoma

 

Dear Dokter,


Saya sudah divonis terkena Penyakit Glukoma, bagaimana caranya menghilangkan penyakit ini?

Bisakah menggunakan dengan cara alternatif?


Mohon jawabannya, terima kasih


Regards

Mono

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (1)

[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

13 Mei 2014

Re: [Dokter Umum] Batu Empedu 4mm

 

Hello,

LANSOPRAZOLE

Kapsul

(Lansoprazole)

Obat Generik : Lansoprazole

Obat Bermerek : Betalans, Compraz, Digest, Gastrolan, Inhipraz, Lancid, Lanpracid, Lanvell, Lapraz, Laproton, Lasgan, Laz, Loprezol, Nufaprazol, Prazotec, Prosogan FD, Protica, Pysolan, Solans, Sopralan, Ulceran.

KOMPOSISI / KANDUNGAN

Tiap kapsul mengandung Lansoprazole pellet yang setara dengan Lansoprazole 30 mg.

FARMAKOLOGI (CARA KERJA OBAT)

Lansoprazole adalah inhibitor sekresi asam lambung yang efektif. Lansoprazole secara efektif menghambat (H+/K+)ATPase (pompa proton) dari sel parietal mukosa lambung.

INDIKASI / KEGUNAAN

Indikasi Lansoprazole adalah :

Ulkus duodenum,
Benign ulkus gaster,
Refluks esofagitis.

KONTRAINDIKASI

Lansoprazole jangan diberikan kepada pasien yang hipersensitif atau alergi terhadap lansoprazole.

DOSIS DAN ATURAN PAKAI

Tanyakan kepada dokter anda mengenai dosis dan aturan pakai Lansoprazole.

Dosis yang lazim diberikan :

Ulkus duodenum : Lansoprazole 30 mg, sekali sehari selama 4 minggu.
Benign ulkus gaster : Lansoprazole 30 mg, sekali sehari selama 8 minggu.
Reflux esofagitis : Lansoprazole 30 mg, sekali sehari selama 4 minggu.

Cara Pemberian

Lansoprazole diberikan sekali sehari. Untuk mencapai efek penghambatan asam yang optimal dan kesembuhan yang cepat dan hilangnya gejala-gejala, Lansoprazole sebaiknya diberikan pagi hari sebelum makan.
Kapsul harus langsung ditelan, tidak boleh digerus atau dikunyah.
Pengobatan jangka panjang dengan Lansoprazole tidak dianjurkan pada saat ini karena pengalaman klinis terbatas.
Orang tua : tidak perlu penyesuaian dosis lansoprazole. Dosis 30 mg sekali sehari.
Anak-anak : tidak ada pengalaman pemberian Lansoprazole pada anak-anak.
Lansoprazole pada dasarnya dimetabolisme di hati. Penelitian klinis pasien dengan penyakit hati, menunjukkan bahwa metabolisme Lansoprazole diperpanjang pada pasien-pasien dengan gangguan fungsi hati yang berat tetapi tidak perlu adanya penyesuaian dosis, dosis tidak boleh melebihi 30 mg sehari.

EFEK SAMPING

Selama penelitian klinis, kadang-kadang dapat terjadi efek samping : sakit kepala, diare, nyeri abdomen, dispepsia, nausea, vomitus, mulut kering, konstipasi, flatulens, pusing, lelah, ruam kulit, urtikaria, pruritus.
Terjadinya kenaikan nilai tes fungsi hati yang bersifat sementara dan akan normal kembali. Tidak diketahui hubungannya dengan terapi Lansoprazole.
Kadang-kadang dapat terjadi : arthralgia, edema perifer dan depresi.
Perubahan angka hematologis seperti trombositopenia, eosinofilia, leukopenia, walaupun jarang, pernah dilaporkan.

PERINGATAN DAN PERHATIAN

Seperti umumnya pada pengobatan dengan antiulkus, kemungkinan keganasan harus disingkirkan bila dicurigai ulkus gaster karena pemberian obat akan meredakan gejala-gejala dan memperlambat diagnosa.
Penggunaan Lansoprazole pada wanita hamil dan menyusui : Belum ada data yang cukup tentang penggunaan Lansoprazole pada wanita hamil, sehingga pemberian Lansoprazole pada wanita hamil dan wanita yang diduga hamil sebaiknya dihindari. Pada percobaan binatang, Lansoprazole tidak terdapat efek teratogenik. Penelitian reproduksi pada tikus dan kelinci dengan Lansoprazole dosis tinggi sedikit menurunkan angka kehidupan dan berat badan pada hewan tersebut. Pada percobaan binatang, Lansoprazole dikeluarkan lewat air susu. Tidak ada informasi mengenai sekresi Lansoprazole pada air susu ibu. Menyusui harus dihentikan apabila benar-benar dianggap perlu menggunakan Lansoprazole.

INTERAKSI OBAT

Lansoprazole dimetabolisme di hati dan merupakan penginduksi yang lemah dari cytochrome P450. Oleh sebab itu ada kemungkinan interaksi dengan obat-obat yang dimetabolisme di hati.
Terutama harus hati-hati bila diberikan bersama-sama dengan obat-obat kontrasepsi oral dan preparat seperti fenitoin, teofilin, atau warfarin.
Tidak menimbulkan efek klinis yang bermakna dengan obat-obat antiinflamasi nonsteroid atau diazepam.
Antasida dan sukralfat akan mengurangi bioavaibilitas Lansoprazole dan jangan diberikan antara satu jam setalah makan Lansoprazole.

KEMASAN

Lansoprazole, Dus, 2 blister @ 10 kapsul.

KETERANGAN

HARUS DENGAN RESEP DOKTER.

Simpan di tempat kering dan sejuk. Jauhkan dari jangkauan anak-anak.
==================================

Urdafalk®
ursodeoxycholic acid
capsule

COMPOSITION
Each capsule contains: ursodeoxycholic acid ... 250 mg

PHARMACOLOGY
Urdafalk® contains ursodeoxycholic acid that work with:
Converts cholesterol precipitates: into readily soluble cholesterol by forming a lecithin cholesterol liquid layer on the surface of gallstones. Ursodeoxycholic acid suppresses hepatotoxicity induced by endogenous bile acids, has a cytoprotective effect to hepatocyte cells and modification from immune system. The hydrophilic ursodeoxycholic acid has detergent effect bind with plasma membrane Immunomodulatory effect showed with reduce the abnormal expression of HLA in hepatocyte. Administration Urdafalk® in patient with gastritis reflux may increase concentration in gastric secrete so that neutralizing aggressive bile acid.

INDICATIONS

  • Radiolucents gallstones not exceeding 20 mm in diameter.
  • Patients who are at increased risk or who refuse cholecystectomy.
  • Liver cholestatic disease. 
DOSAGE AND ADMINISTRATIONS
8 - 10 mg / kg body weight / day in 2 or 3 divided doses, taken with milk or meal (usually 250 mg is given in the morning and in the afternoon).
Urdafalk® capsules must be taken regularly to ensure success. Therapy should be reinstituted from the beginning if there is an interruption for 4 weeks.

WARNING AND PRECAUTIONS
  • Gallbladder stone dissolution with Ursodeoxycholic acid requires months of therapy. Therefore, caution should be exercised during therapy with Ursodeoxycholic acid and alternative therapies should be considered.
  • Complete dissolution does not occur in all patients and recurrence of stones within 5 years has been observed in up to 50% of patient.
  • Ursodeoxycholic acid is not recommended for pregnant and nursing mothers.
  • The safety and effectiveness of ursodeoxycholic acid in children have not been established. 
SIDE EFFECTS
Side effects include diarrhea, pruritus, skin rash, urticaria, dry skin, cold sweat, hair loss, nausea, vomiting, indigestion, metallic taste, abdominal pain, biliary pain, cholecystitis, constipation, stomatitis, flatulence, dizziness, fatigue, anxiety, depression, sleep disolder, arthtralgia, myalgia, back pain, cough, and rhinitis, gallstone calcification.

CONTRAINDICATIONS
  • Calcified cholesterol stones, radiopaque stones or radiolucent bile pigment stones.
  • Unremitting acute cholecystitis, cholangitis, biliary obstruction, pancreatitis or biliary gastrointestinal fistula.
  • Bile tract obstruction.
  • Pregnancy.
  • Gallstone calcification.
  • Non-functioning gall bladder.
  • Inflammatory diseases and other conditions of the small intestine.
  • Colon and liver which interfere with entero hepatic circulation of bile salts. 
DRUG INTERACTIONS
Cholestyramine or Aluminium hydroxide block the absorption of ursodeoxycholic acid.
Estrogen, oral contraceptives and clofibrate (and perhaps other lipid-lowering drugs) increase hepatic cholesterol secretion, and encourage cholesterol gallstone formation and hence may counteract the effectiveness of Urdafalk®.

Cholestyramine atau Aluminium hidroksida memblokir penyerapan asam ursodeoxycholic.
Estrogen, kontrasepsi oral dan clofibrate (dan mungkin obat penurun lipid lainnya) meningkatkan sekresi kolesterol hati, dan mendorong pembentukan batu empedu kolesterol dan karenanya mungkin menetralkan efektivitas Urdafalk ®


Laboratory monitor:
Current scientific findings suggest that during the first three months of treatment for gallstone dissolution, the routine function tests (serum levels of transaminases, bilirubin and alkaline phosphate) should be determined fortnightly. Later these tests need to be carried out every three weeks.

Duration of treatment:
Pure cholesterol gallstone dissolve after a period of 6 month to years. To ensure the success of therapy, bile ducts should be monitored by X-ray, if there is no change in gallstone size after 2 years, further treatment will not give good result.

ON DOCTOR'S PRESCRIPTION ONLY
Store at 25° - 30° C


PRESENTATION
Box of 30 capsules in 6 strips of 5 capsules
Reg. No.: DKL9104508601A1

Manufactured by:
Darya-Varia
LABORATORIA
Gunung Putri, Bogor-lndonesia

Pertanyaanya:

yg membentuk batu itu apa?
Bila minyak yg dikonsumsi n itu tdk dieliminir, lalu pemberian Olive oil apakah bukan minyak?
Bagaimana rekasi tubuh ketika di berikan minyak tersebut? apakah kompatibel dg tubuh Olive oil itu? n memberikan reaksi positif utk menetralkan minyak tubuh?

Seingat saya komposisi mengandung garam ingris, sedangkan yg anda pakai, dipenggal sebagaian.

Obat yg diberikan internis, perlu di lakukan monitoring, tetapi bukan dg berbarenagan memberikan berbagai percobaan.

Jadi?

Salam,


On 5/7/2014 8:48 AM, erma_santiz@yahoo.com wrote:

Yth Dokter...

Berdasarkan hasil usg suami saya, ditemukan batu empedu uk.0.4mm, Dokter Internis memberikan 2 opsi : operasi ataukah obat, kami memilih obat ( krn hasil obrolan dgn dokter USG uk. batu msh relatif kecil dan bs didorong keluar dgn obat2an). Atas pilihan kami tersebut, kami diberikan obat LANSOPRAZOLE 30mg (1Xsehari) dan URDAFALK 250mg (2xsehari) utk 10 hari dgn catatan 10 hari kemudian dilakukan kontrol lg.
Namun setelah 2 hari mengkonsumsi obat itu mual,muntah, badan lemas dan keringat dingin msh saja dialami oleh suami saya.
Saat ini saya jg lakukan treatment rekomendasi seorang teman yakin apel (di jus dan disaring tiap pagi dan sore) dan jeruk lemon yg dicampur dgn olive oil. Yang mau saya tanyakan:
1. Apakah obat2 yg diresepkan oleh dokter internis itu sdh tepat Dok?mengingat keluhannya msh saja dirasakan oleh suami saya
2. Apakah treatment apel dan sari lemon itu sdh tepat utk peluruhan batu empedu dan apakah aman dikonsumsi berbarengan dgn obat resep dokter itu?
3. Treatment apa dan pantangan makanan apa yg sbaiknya dilakukan Dok?
4. Utk uk. batu empedu seukuran itu apakah bisa dikeluarkan alami dengan obat2an atau dengan cara lain Dok, tanpa perlu dilakukan operasi?klw bisa, mohon dengan cara/obat/herbal apa ya Dok?

Demikian Dok, mohon pencerahannya.. Terimakasih banyak Dok..





--
We Care

-- We care human as human not as sickness object

 "Absolutely Drug less Health Care solution Organization"

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (2)

[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

Re: [Dokter Umum] tanya : efek minum Fenofibrate 200 mg

 

Hello,

Fenofibrate 200 mg capsules

4. Clinical particulars

4.1 Therapeutic indications

Fenofibrate 200 mg capsules are indicated as an adjunct to diet and other non pharmacological treatment (e.g. exercise, weight reduction) for the following:

- Treatment of severe hypertriglyceridaemia with or without low HDL cholesterol.

- Mixed hyperlipidaemia when a statin is contraindicated or not tolerated.

- Mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and HDL cholesterol are not adequately controlled.



4.2 Posology and method of administration

Adults

The recommended initial dose is one capsule taken daily during a main meal. In elderly patients without renal impairment, the normal adult dose is recommended. Since it is less well absorbed from an empty stomach, Fenofibrate 200 mg capsules should always be taken with food. Dietary restrictions instituted before therapy should be continued.

Response to therapy should be monitored by determination of serum lipid values. Rapid reduction of serum lipid levels usually follows Fenofibrate 200 mg capsule treatment, but treatment should be discontinued if an adequate response has not been achieved within three months.

Renal failure

A dose reduction is recommended in renal impairment (see section 4.4)

Paediatric population

The safety and efficacy of fenofibrate in children and adolescents younger than 18 years has not been established. No data are available. Therefore, the use of fenofibrate is not recommended in paediatric subjects under 18 years



4.3 Contraindications

Fenofibrate 200 mg capsules are contraindicated in children, in patients with severe liver dysfunction, gallbladder disease, bilary cirrhosis, severe renal disorders and in patients hypersensitive to fenofibrate or any component of this medication, known photoallergy or phototoxic reaction during treatment with fibrates or ketoprofen.

Chronic or acute pancreatitis with the exception of acute pancreatitis due to severe hypertriglyceridemia.

Use during pregnancy and lactation (see section 4.6).

This medicine contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.


4.4 Special warnings and precautions for use

Secondary causes of dyslipidaemia, such as uncontrolled type 2 diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemia, obstructive liver disease, pharmacological treatment, alcoholism, should be adequately treated before fenofibrate therapy is initiated.

Response to therapy should be monitored by determination of serum lipid values (total cholesterol, LDL-C, triglycerides). If an adequate response has not been achieved after several months (e.g. 3 months) complementary or different therapeutic measures should be considered.

Renal impairment

In renal dysfunction the dose of fenofibrate may need to be reduced, depending on the rate of creatinine clearance. In this case, Fenofibrate 67 mg capsules should be used, e.g. 2 Fenofibrate 67 mg capsules daily for creatinine clearance levels of <60 ml/min and 1 Fenofibrate 67 mg capsule daily for creatinine clearance levels of <20 ml/min.

It is recommended that creatinine is measured during the first three months after initiation of treatment and thereafter periodically. Treatment should be interrupted in case of an increase in creatinine levels > 50% of (upper limit of normal).

Use of Fenofibrate 67 mg capsules are also to be preferred in elderly patients with renal impairment where dosage reduction may be required.

Serum Transaminases

Moderately elevated levels of serum transaminases may be found in some patients but rarely interfere with treatment. However, it is recommended that serum transaminases should be monitored every three months during the first twelve months of treatment. Treatment should be interrupted in the event of ALAT (SGPT) or ASAT (SGOT) elevations to more than 3 times the upper limit of the normal range or more than one hundred international units.

Pancreatitis

Pancreatitis has been reported in patients taking fenofibrate (see section 4.8). This occurrence may represent a failure of efficacy in patients with severe hypertriglyceridaemia, a direct drug effect, or a secondary phenomenon mediated through biliary tract stone or sludge formation, resulting in the obstruction of the common bile duct.

Myopathy

Muscle toxicity, including very rare cases of rhabdomyolysis, has been reported with administration of fibrates and other lipid-lowering agents. The incidence of this disorder increases in cases of hypoalbuminaemia and previous renal insufficiency. Patients with pre-disposing factors for myopathy and/or rabdomyolysis, including age above 70 years, personal or family history of hereditary muscular disorders, renal impairment, hypothyroidism and high alcohol intake, may also be at an increased risk of developing rabdomyolysis. For these patients, the putative benefits and risks of fenofibrate therapy should be carefully weighed up. Muscle toxicity should be suspected in patients presenting diffuse myalgia, myositis, muscular cramps and weakness and/or marked increases in CPK (levels exceeding 5 times the normal range). In such cases treatment with fenofibrate should be stopped.

The risk of muscle toxicity may be increased if the drug is administered with another fibrate or an HMG-CoA reductase inhibitor, especially in cases of pre-existing muscular disease. Consequently, the co-prescription of fenofibrate with a statin should be reserved to patients with severe combined dyslipidaemia and high cardiovascular risk without any history of muscular disease. This combination therapy should be used with caution and patients should be monitored closely for signs of muscle toxicity.

For hyperlipidaemic patients taking oestrogens or contraceptives containing oestrogen it should be ascertained whether the hyperlipidaemia is of primary or secondary nature (possible elevation of lipid values caused by oral oestrogen).



4.5 Interaction with other medicinal products and other forms of interaction

Oral anti-coagulants

Fenofibrate enhances oral anti-coagulant effect and may increase risk of bleeding. In patients receiving oral anti-coagulant therapy, the dose of anti-coagulant should be reduced by about one-third at the commencement of treatment and then gradually adjusted if necessary according to INR (International Normalised Ratio) monitoring.

HMG-CoA reductase inhibitors or Other Fibrates

The risk of serious muscle toxicity is increased if fenofibrate is used concomitantly with HMG-CoA reductase inhibitors or other fibrates. Such combination therapy should be used with caution and patients monitored closely for signs of muscle toxicity(see Section 4.4).

There is currently no evidence to suggest that fenofibrate affects the pharmacokinetics of simvastatin.

Ciclosporin

Some severe cases of reversible renal function impairment have been reported during concomitant administration of fenofibrate and ciclosporin. The renal function of these patients must therefore be closely monitored and the treatment with fenofibrate stopped in the case of severe alteration of laboratory parameters.

Other

No proven clinical interactions of fenofibrate with other drugs have been reported, although in vitro interaction studies suggest displacement of phenylbutazone from plasma protein binding sites. In common with other fibrates, fenofibrate induces microsomal mixed-function oxidases involved in fatty acid metabolism in rodents and may interact with drugs metabolised by these enzymes.


4.8 Undesirable effects

The adverse drug reactions are stated in the table below using the following convention:

Very common (>1/10); common (>1/100; <1/10); uncommon (>1/1,000; <1/100); rare (>1/10,000; <1/1,000); very rare (<1/10,000) including isolated reports.

Blood and lymphatic system disorders

Rare:

Decrease in haemoglobin and leukocytes

Nervous system disorders

Common:

Headache

Rare:

Peripheral neuropathy

Ear and labyrinth disorders

Common:

Vertigo

Vascular disorders

Uncommon:

Thromboembolism (pulmonary embolism, deep vein thrombosis)*

Respiratory, thoracic and mediastinal disorders

Very rare:

Interstitial pneumopathies

Gastrointestinal disorders

Common:

Digestive, gastric or intestinal disorders (abdominal pain, nausea, vomiting, diarrhoea, and flatulence)

Uncommon:

Pancreatitis*

Hepato-biliary disorders

Uncommon:

Elevated levels of serum transaminases (see section 4.4)

Very rare:

hepatitis (see section 4.4), gallstones

Skin and subcutaneous tissue disorders

Common:

Reactions such as rashes, pruritus, urticaria or photosensitivity reactions; cutaneous photosensitivity may occur with erythema, vesiculation or nodulation on parts of the skin exposed to sunlight or artificial UV light (e.g. sun lamp)

Rare:

Alopecia

Musculoskeletal, connective tissue and bone disorders

Uncommon:

muscle toxicity (diffuse myalgia, myositis, muscular cramps and weakness) (see section 4.4)

Very rare:

Rhabdomyolysis. (see section 4.4)

Renal and urinal disorders

Rare:

Increases in serum creatinine and urea

General disorders and administration site conditions

Common:

Fatigue

Rare:

Sexual asthenia




On 5/7/2014 9:02 AM, Ari_S wrote:
Dear Teman dan Dokter Milis.
 
Ingin bertanya, saya karena trigleserida yang agak tinggi, sedang minum fenofibrate 200mg.
Apakah ada efek nya..?
 
Saya merasakan saat ini seperti susah bernafas..
apakah ini efek dari obat ini  atau bukan..?
 
thanks
Ari


--
We Care

-- We care human as human not as sickness object

 "Absolutely Drug less Health Care solution Organization"

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (2)

[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

06 Mei 2014

[Dokter Umum] tanya : efek minum Fenofibrate 200 mg

 

Dear Teman dan Dokter Milis.
 
Ingin bertanya, saya karena trigleserida yang agak tinggi, sedang minum fenofibrate 200mg.
Apakah ada efek nya..?
 
Saya merasakan saat ini seperti susah bernafas..
apakah ini efek dari obat ini  atau bukan..?
 
thanks
Ari

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (1)

[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

[Dokter Umum] Batu Empedu 4mm

 

Yth Dokter...

Berdasarkan hasil usg suami saya, ditemukan batu empedu uk.0.4mm, Dokter Internis memberikan 2 opsi : operasi ataukah obat, kami memilih obat ( krn hasil obrolan dgn dokter USG uk. batu msh relatif kecil dan bs didorong keluar dgn obat2an). Atas pilihan kami tersebut, kami diberikan obat LANSOPRAZOLE 30mg (1Xsehari) dan URDAFALK 250mg (2xsehari) utk 10 hari dgn catatan 10 hari kemudian dilakukan kontrol lg.
Namun setelah 2 hari mengkonsumsi obat itu mual,muntah, badan lemas dan keringat dingin msh saja dialami oleh suami saya.
Saat ini saya jg lakukan treatment rekomendasi seorang teman yakin apel (di jus dan disaring tiap pagi dan sore) dan jeruk lemon yg dicampur dgn olive oil. Yang mau saya tanyakan:
1. Apakah obat2 yg diresepkan oleh dokter internis itu sdh tepat Dok?mengingat keluhannya msh saja dirasakan oleh suami saya
2. Apakah treatment apel dan sari lemon itu sdh tepat utk peluruhan batu empedu dan apakah aman dikonsumsi berbarengan dgn obat resep dokter itu?
3. Treatment apa dan pantangan makanan apa yg sbaiknya dilakukan Dok?
4. Utk uk. batu empedu seukuran itu apakah bisa dikeluarkan alami dengan obat2an atau dengan cara lain Dok, tanpa perlu dilakukan operasi?klw bisa, mohon dengan cara/obat/herbal apa ya Dok?

Demikian Dok, mohon pencerahannya.. Terimakasih banyak Dok..

Sent from Yahoo Mail on Android

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (1)

[ Forum Kesehatan : http://www.medisiana.com ]

.

__,_._,___

05 Mei 2014

Re: [Dokter Umum] Sakit kepala dan sesak nafas yang terus menerus

 

Hello,

Yap, Parfume bukan arromatic, itu chemical blend dg alkohol n bisa yg aneh2 seperti kulit sapi, tembakau dlsbnya.
Tdk hanya sekedar dari symptoms lalu ketemu apa yg terjadi.
Allergy, ya, penyebabnya? belum tentu, bisa saja tekanan darah dlsbnya.
jadi mesti dicari
Salam,


On 5/6/2014 9:41 AM, maulanaprianti@yahoo.co.id wrote:

Hallo dok,

yang saya maksud dengan aroma wewangian adalah spt parfume. bahkan saat melihat matahari atau lampu, pasti sakit kepala..

umumnya sakit kepala yg saya rasakan lebih condong ke kepala yg sebelah kanan. berawal dari alis mata sebelag kanan, sampai atas kepala..

apakah sakit kepala trsebut berpengaruh karna alergi hidung yg saya alami???

Sent from Yahoo Mail on Android



From: Dr.(Naturopathy) Ir. Donny Hosea MBA. PhD. Acs <puyuh23@indo.net.id>;
To: <dokter_umum@yahoogroups.com>;
Subject: Re: [Dokter Umum] Sakit kepala dan sesak nafas yang terus menerus
Sent: Mon, May 5, 2014 10:28:14 AM

 

Hello,

Aroma tdk selalu merukqan arromatic.
Jadi perlu ketegasan yg anda cium apakah chemical aroma atau arromatic essential.

duduk ke berdiri membuat perbedaan tekanan udara, bila ada gangguan keseimbangan, maka sangat mempengaruhi.
Apalagi bila flow darah cukup terganggu dlm artian, kekentalan n kandunganya.

So dg informasi yg sangat minim ini tdk ada yg bisa di tegakan.

Salam,

On 5/2/2014 9:41 PM, maulanaprianti@yahoo.co.id wrote:

Malam dok,
saya prianti, wanita 23th 5bln.

Dok, saya sering sekali sakit kepala sampai muntah2, ngga bisa cium aroma wewangian yang terlalu tajam, kalau abis duduka, saat berdiri pasti sakit sekali kepalanya, sering bersin kalau kena debu, apalagi kalau sesak nafas, itu sakitnya sakit sekali.

sebelumnya saya Sudah pernah berobat, tapi saya cuma dikatakan alergi, dan dikasih obat avamys nasal spray..
tetapi itu hanya membantu saya mengeluarkan lendir saat flu, karna saya saat flu sering bahkan tidak dpt mebgeluarkan lendir.

yang ingin saya tanyakan, sakit kepala saya itu karna apa ya?? kira2 apa yg harus saya lakukan untuk menghilangkan rasa sakit kepala itu??


--



--
We Care

-- We care human as human not as sickness object

 "Absolutely Drug less Health Care solution Organization"

__._,_.___
Reply via web post Reply to sender Reply to group Start a New Topic Messages in this topic (4)

[ Forum Kesehatan : http://www.medisiana.com ]
.

__,_._,___